Get started
Author

Claire Stampfli

Observed names: C Stampfli, C. Stampfli, C. Stämpfli, Camille Stampfli, Stampfli, C., Stampfli, Camille Léonie
Observed institutions: University of Geneva, Centre Hospitalier Universitaire Vaudois, Centre Hospitalier Universitaire de Besançon, Hôpital Lyon Sud, Hôpital Orthopédique de la Suisse Romande, Centre François Baclesse, Centre Jean Bernard, Centre Hospitalier d'Albi, University of Lausanne
ORCID: 0000-0002-6659-0790
Observed ORCID: 0000-0002-6659-0790
OpenAlex ID: A5010336545
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach
2017 · Michele Boisdron-Celle, Olivier Capitain, et al. · Seminars in Oncology · 82
Primary carcinoma of the gall-bladder: potential for external radiation therapy
1994 · Marc Mahe, Claire Stampfli, et al. · Radiotherapy and Oncology · 47
Comparison of 4 Screening Methods for Detecting Fluoropyrimidine Toxicity Risk: Identification of the Most Effective, Cost-Efficient Method to Save Lives
2020 · Olivier Capitain, Valérie Seegers, et al. · Dose-Response · 15
Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases
2024 · Florian Blanchard, Benoît Henry, et al. · The Lancet Infectious Diseases · 11
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio
2024 · Nicolas Benech, Nadim Cassir, et al. · Gastroenterology · 10
Prevention of 5-FU-induced health-threatening toxicity by pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach.
2013 · Michele Boisdron-Celle, Olivier Capitain, et al. · Journal of Clinical Oncology · 8
A critical opinion-based review of hospital pharmacy compounding with respect to the risk of leachable substances due to the off-label use of plastic primary packaging
2025 · William Bello, Julian Pezzatti, et al. · Therapeutic Advances in Drug Safety · 7
Clinical value of saliva therapeutic drug monitoring of newer antiseizure medications
2025 · Eva Choong, Paola Vassallo, et al. · Seizure · 5
PDF
Prevention of 5-FU-induced toxicities using pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach.
2013 · Michele Boisdron-Celle, Olivier Capitain, et al. · Journal of Clinical Oncology · 4
Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post–EMA-approval descriptive study with a geriatric oncology focus
2020 · Jean-Philippe Metges, Jean-Yves Douillard, et al. · The Turkish Journal of Gastroenterology · 3
PDF
Is the salivary concentration of lamotrigine and levetiracetam associated with clinical outcome?
2025 · Paola Vassallo, Eva Choong, et al. · Epilepsy & Behavior · 2
PDF
Stability study of topotecan in ophthalmic prefilled syringes for intravitreal delivery
2025 · William Bello, Camille Hosotte, et al. · European Journal of Hospital Pharmacy · 2
PDF
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics
2014 · J. P. Metges, M. A. Lebot, et al. · ONCOLOGIE · 2
PDF
Fecal Microbiota Transplantation Donor Screening: Is Dientamoeba fragilis a Valid Criterion for Donor Exclusion? A Longitudinal Study of a Swiss Cohort
2026 · Keyvan Moser, Aurelie Ballif, et al. · Microorganisms · 1
PDF
Assessment of leachables in hospital pharmacy compounded topotecan conditioned in common off-label syringes for intravitreal use
2025 · William Bello, Camille Hosotte, et al. · Scientific Reports · 1
PDF
Excess volume addition method improves human resource efficiency and environmental sustainability of cytotoxic drug preparations
2025 · Marie Kroemer, Guillaume Galy, et al. · Journal of Oncology Pharmacy Practice · 1
EGFR Expression Is Unreliable to Decide for Cetuximab Treatment in Patients with Metastatic Colorectal Cancer: Results from “ERBITUX-OUEST”
2016 · Jean-Philippe Metges, Erick Gamelin, et al. · Open Journal of Internal Medicine · 1
PDF
Is panitumumab monotherapy safe in metastatic colorectal cancer patients over 70 years old?
2015 · Jerome Martin-Babau, Jean-Yves Douillard, et al. · Journal of Clinical Oncology · 1
3603 Management of unresectable metastatic colorectal cancer (MRCC) in the real world with successive regimens with targeted therapies (Bevacizumab and cetuximab): the experience of the OMIT Bretagne Pays de Loire
2009 · J.P. Metges, E. Gamelin, et al. · European Journal of Cancer Supplements · 1
Transplantation de microbiote fécal: la détection de Dientamoeba fragilis doit-elle exclure les donneurs ? Une étude de cohorte longitudinale
2025 · K. Moser, A. Ballif, et al. · Médecine et Maladies Infectieuses Formation
2SPD-027 Medication storage temperatures inside emergency vehicles: a pilot study in a temperate climate country
2022 · C Stampfli, JC Devaud, et al.
PDF
Screening patients for fluoropyrimidine-related toxicity risk.
2019 · Olivier Capitain, Valérie Seegers, et al. · Journal of Clinical Oncology
Primum non nocere: Screening patients for fluoropyrimidine-related toxicity risk: The most effective method
2018 · M. Boisdron-Celle, J. Metges, et al. · Annals of Oncology
Identification of predictive factors for postoperative gastro-intestinal Clavien Dindo grade III-IV complications in patients undergoing advanced ovarian cancer surgery.
2018 · Jarmila A. Zdanowicz, ML Gasparri, et al. · BORIS (University Library Bern)
In reply
2017 · Michele Boisdron-Celle, Olivier Capitain, et al. · Seminars in Oncology
Works count: 33
Citation count: 204
H-index: 7
I10-index: 5
Year
Topic
Type